HEARINGS

BEFORE THE

SUBCOMMITTEE ON ANTITRUST AND MONOPOLY

OF THE

COMMITTEE ON THE JUDICIARY
UNITED STATES SENATE

EIGHTY-SEVENTH CONGRESS

FIRST SESSION

PURSUANT TO

S. Res. 52

ON

S. 1552

A BILL TO AMEND AND SUPPLEMENT THE ANTITRUST
LAWS, WITH RESPECT TO THE MANUFACTURE AND DIS-
TRIBUTION OF DRUGS, AND FOR OTHER PURPOSES

73753

PART 2

A.M.A. and Medical Authorities

(Appendix)

Printed for the use of the Committee on the Judiciary

U.S. GOVERNMENT PRINTING OFFICE

WASHINGTON: 1961

For sale by the Superintendent of Documents, U.S. Government Printing Office
Washington 25, D.C. Price $2.25

1. Report of special committee advisory to the Secretary of Health,

Education, and Welfare to review the policies, procedures, and deci-

sions of the Division of Antibiotics and the New Drug Branch of the

Food and Drug Administration; National Academy of Sciences-

National Research Council...

2. Letter from Council on Drugs to doctors re serving as consultants in
evaluations of drugs..

3. Report to the Secretary of Health, Education, and Welfare concerning

the Food and Drug Administration, by Charles H. Kendall, General

Counsel, Office of Civil and Defense Mobilization

4. Principles governing advertising in the AMA scientific publications

5. "Doctors, Drugs, and Names," Dr. Lloyd C. Miller, Director of Revision,

USP, J.A.M.A., July 8, 1961-

Part I.

490

Part II.

521

6. Report on a study of advertising and the American physician.

The advertisers' viewpoint-an opinion survey made for the Ameri-

can Medical Association by Ben Gaffin & Associates..

7. A study of medical advertising and the American physician.

The physicians' viewpoint-an opinion survey made for the Ameri-

can Medical Association by Ben Gaffin & Associates..

8. The Fond du Lac study: An intensive study of the marketing of five

new ethical pharmaceutical products in a single market, resulting in

some theory of scientific marketing and service programs for action—

a basic marketing study made for the American Medical Association

by Ben Gaffin & Associates. Chapter I. Objectives...

9. A study of medical advertising and the American physician. Part II.

The physicians' viewpoint-an opinion survey made for the Ameri-

can Medical Association by Ben Gaffin & Associates.

Attitudes of physicians toward council acceptance.-

10. Expenses of AMA councils, bureaus, and related activities, 1950-58--

11. Letter from Dr. Blasingame, American Medical Association, July 24,

1961, relating to Council on Drugs appropriations...

525

Chapter VII.

528

530

531

12. AMA income by source, 1949-60 (subcommittee chart).
13. Pages of advertising in J.A.M.A., January to March, 1953–61 (subcom-
mittee chart) –

128

131

14. Advertising expenditures in J.A.M.A., 22 selected drug companies,
1955, 1958, 1960 (subcommittee chart).

132

15. AMA statement of income, year ended December 31, 1960, with

comparative figures for 1959.

534

16. AMA income from addressing companies.

535

17. "Why we sometimes ask questions

*" ad from J.A.M.A., August

6, 1960.

536

*

18. "Clarity is our aim **" ad from J.A.M.A., September 10, 1960__

19. DBI ad, J.A.M.A., February 25, 1961.

538

540

20. "Clinical Evaluation of Phenformin (DBI) in Office Practice," Dr.

Paul L. Barclay, Erie, Pa., J.A.M.A., October 1, 1960..

542

21. Equanil ad, J.A.M.A., March 4, 1961-

549

22. Miltown ad, J.A.M.A., March 11, 1961

551

23. Statement on side effects of meprobamate, from New and Nonofficial

Drugs, 1961.

553

24. Soma ad, J.A.M.A., April 30, 1960-

554

25. Tenuate ad, J.A.M.A., July 9, 1960, and "Status and Prospect of

Drugs for Overeating," Report to the Council on Drugs, Dr. Walter

Modell, J.A.M.A., July 9, 1960.

556

Exhibits below p. 459 may be found in pt. 1.

III